줄기세포주 등록제도의 법적 분쟁을 둘러싼 법원 판단의 문제점 - 대법원 2015. 6. 24. 선고 2013두24433 판결을 중심으로 -

In May 2015, Professor Hwang Woo Suk applied for stem cell line registration for Sooam-hES1 stem cell line established in April 2003 based on the then Bioethics and Safety Act. However, the Korea Centers for Disease Control and Prevention reject the application, citing that the stem cell line of the case was inappropriate for registration. Then, Professor Hwang raised an appeal against the decision about October, 2010. As the KCDC dismissed it, he raised an action against the KCDC to cancel its rejection to the stem cell line registration in November of the year. The court ruled to cancel the rejection and the ruling was supported by the Supreme Court. In November, 2016, the KCDC permits its registration. In this background, this study focuses on the ethical and legal problems regarding the registration of already-established embryonic stem cell line and reviews the court’s stance about the CDC disposal and ground of ruling to see if there is any problem in court decision. To this end, this study discusses the relationship between stem cell line registration and ethics, purpose of introducing the stem cell line registration scheme, legal characteristics of stem cell line registration, legitimacy of the rejection, etc.